C. Seitz

发表

Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

C. Gerlinger, T. Faustmann, F. Petraglia, 2011, Archives of Gynecology and Obstetrics.

Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis

C. Gerlinger, T. Faustmann, T. Strowitzki, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data.

S. Shariat, C. Cao, E. Schernhammer, 2020, European urology focus.

Observation Versus Active Treatment

H. Fajkovic, C. Seitz, 2013 .

Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

M. Remzi, S. Shariat, H. Fajkovic, 2011, Therapeutic advances in urology.

Role of lasers in urology

S. Shariat, H. Fajkovic, C. Seitz, 2019, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

A systematic review of methods to measure menstrual blood loss

C. Gerlinger, C. Seitz, S. O’Brien, 2018, BMC Women's Health.

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.

J. Simon, C. Seitz, K. Gemzell‐Danielsson, 2019, Fertility and sterility.

Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review

C. Gerlinger, C. Seitz, J. Magnay, 2020, BMC Women's Health.

Epidemiological gender-specific aspects in urolithiasis

H. Fajkovic, C. Seitz, 2013, World Journal of Urology.

Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers.

C. Gerlinger, C. Seitz, T. Nevatte, 2014, Fertility and sterility.

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials

C. Gerlinger, T. Faustmann, C. Seitz, 2012, BMC Women's Health.

Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors.

C. Seitz, Paul M Overton, R. Schulze‐Rath, 2022, European journal of obstetrics, gynecology, and reproductive biology.

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

C. Gerlinger, T. Faustmann, T. Strowitzki, 2015, International journal of women's health.

Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.

A. Ebert, H. Roman, B. Böttcher, 2017, Journal of pediatric and adolescent gynecology.

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.

C. Gerlinger, T. Faustmann, T. Strowitzki, 2010, Human reproduction.

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study.

C. Gerlinger, T. Faustmann, T. Strowitzki, 2010, European journal of obstetrics, gynecology, and reproductive biology.

A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis

C. Gerlinger, T. Faustmann, A. Mueck, 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2.

T. Faustmann, C. Seitz, O. Heikinheimo, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.

M. Schultze-Mosgau, B. Rohde, C. Seitz, 2016, Human reproduction.

Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)

C. Gerlinger, T. Willgoss, H. Kitchen, 2021, Health and Quality of Life Outcomes.

Validation of the SF-36 in patients with endometriosis

D. Stull, C. Gerlinger, R. Wasiak, 2009, Quality of Life Research.

A new menstrual pictogram for use with feminine products that contain superabsorbent polymers.

C. Seitz, T. Nevatte, J. Magnay, 2013, Fertility and sterility.

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

C. Gerlinger, T. Faustmann, T. Strowitzki, 2009 .

Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)

C. Gerlinger, C. Seitz, C. Haberland, 2020, Journal of Patient-Reported Outcomes.

Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

H. Doll, C. Gerlinger, C. Seitz, 2020, Journal of Patient-Reported Outcomes.

Patterns of missing data in the use of the endometriosis symptom diary

C. Gerlinger, F. Oehmke, H. Tinneberg, 2018, BMC Women's Health.

Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure–response modelling and simulation

B. Ploeger, M. Schultze-Mosgau, C. Seitz, 2021, British journal of clinical pharmacology.

Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids.

Y. Jacquemyn, G. Melis, C. Seitz, 2017, Contemporary clinical trials.

Results of the asteroid (assess safety and efficacy of vilaprisan in patients with uterine fibroids) 1 study: a phase 2, placebo-controlled dose finding study

C. Seitz, Xiaowei Ren, L. Bradley, 2016 .

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)

J. Bolognese, N. Panay, J. Simon, 2023, Menopause.

Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials

C. Gerlinger, T. Faustmann, A. Colligs, 2010, Health and quality of life outcomes.

Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers.

C. Gerlinger, C. Seitz, T. Nevatte, 2014, Fertility and sterility.